Deucrictibant XR Reduces Hereditary Angioedema Attacks

Evidence Source gap catch-up · Published September 8, 2026 · Discovery September 8, 2026 · Importance 5/5 · Direction Positive Summary Pharvaris reported that once-daily oral deucrictibant XR reduced mean monthly hereditary-angioedema attack rates by 83% versus placebo in the pivotal Phase III CHAPTER-3 study.…